Market capitalization | JPY1.70t |
Enterprise Value | JPY1.41t |
P/E (TTM) P/E ratio | 17.79 |
EV/FCF (TTM) EV/FCF | 17.10 |
EV/Sales (TTM) EV/Sales | 2.97 |
P/S ratio (TTM) P/S ratio | 3.58 |
P/B ratio (TTM) P/B ratio | 1.98 |
Dividend yield | 1.80% |
Last dividend (FY24) | JPY58.00 |
As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.
11 Analysts have issued a Kyowa Kirin forecast:
11 Analysts have issued a Kyowa Kirin forecast:
Jun '24 | |
Current assets | 543,420 543,420 |
Fixed assets | 526,589 526,589 |
Total Assets | 1,070,009 1,070,009 |
Jun '24 | |
Equity | 862,688 862,688 |
Debt capital | 207,322 207,322 |
Total Capital | 1,070,010 1,070,010 |
In millions JPY.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It operates through the Pharmaceuticals and Bio-Chemicals segments. The Pharmaceuticals segment deals with the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. The Bio-Chemicals segment produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan.
Head office | Japan |
CEO | Masashi Miyamoto |
Employees | 5,974 |
Founded | 1949 |
Website | www.kyowa-kirin.co.jp |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.